References
- Surgenor DM, Schnitzer SS. The nation's blood resource. US Department of Health and Human Services, Bethesda MD 1985, NIH publication No. 85-2028
- Curran JW, Lawrence DN, Jaffe H, et al. Acquired immunodeficiency syndrome (AIDS) associated with transfusions. N Engl J Med 1984; 310: 69–75
- Attitudes of U.S. adults toward AIDS and the safety of the American blood supply. American Association of Blood Banks December, 1985
- Aach RD, Szmuness W, Mosley JW, et al. Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients: the Transfusion Transmitted Viruses Study. N Engl J Med 1981; 304: 989–94
- Koziol DE, Holland PV, Ailing DW, et al. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Int Med 1986; 104: 488–95
- Surgenor DM, Wallace EL, Hao HS, Chapman RH. Collection and transfusion of blood in the United States, 1982-1988. N Engl J Med 1990; 322: 1646–51
- Wallace EL, Surgenor DM, Hao HS, Chapman RH, Churchill WH. Collection and transfusion of blood and blood components in the United States 1989. Transfusion 1993; 33: 139–44
- Toy TCY, Strauss RG, Stehling LC, et al. Predeposited autologous blood for elective surgery. N Engl J Med 1987; 316: 517–20
- Starkey JM, MacPherson JL, Bolgiano DC, Simon ER, Zuck TF, Sayers MH. Markers for transfusion-transmitted disease in different groups of blood donors. JAMA 1989; 262: 3452–4
- Kruskall MS, Umlas J. Acquired immunodeficiency syndrome and directed blood donations. A dilemma for American medicine. Arch Surg 1988; 123: 23–5
- Dzik WH, Jenkins R. Use of intraoperative blood salvage during orthotopic liver transplantation. Arch Surg 1985; 120: 946–8
- Donahue JG, Munoz A, Ness PM, et al. The declining risk of posttransfusion hepatitis C virus infection. N Engl J Med 1992; 327: 369–73
- Dodd RY. The risk of transfusion transmitted infection. N Engl J Med 1992; 327: 419–20
- Brunson ME, Alexander JW. Mechanisms of transfusion-induced immunosuppression. Transfusion 1990; 30: 651–8
- Blumberg N, Heal JM. Transfusion and host defenses against cancer recurrence and infection. Transfusion 1989; 29: 236–45
- Ness PM, Walsh M, Zahurak M, Baldwin ML, Piantadosi S. Prostate cancer recurrence in radical surgery patients receiving autologous or homologous blood. Transfusion 1992; 32: 31–6
- Busch MP, Lee T-H, Heitman J. Allogeneic leukocytes but not therapeutic blood elements induce reactivation and dissemination of latent HIV-1 infection: implications for transfusion support of infected patients. Blood 1992; 80: 1893–7
- Bednarik DP, Folks TM. Mechanisms of HIV-1 latency. AIDS 1992; 6: 3–16
- Vamvakas E, Kaplan HS. Early transfusion and length of survival in acquired immune deficiency syndrome: experience with a population receiving medical care at a public hospital. Transfusion 1993; 33: 111–18
- Consensus Conference: Perioperative red blood cell transfusion. JAMA 1988; 260: 2700–3
- Carson JL, Spence RK, Poses RM, Bonavita G. Severity of anemia and operative mortality and morbidity. Lancet 1988; 1: 727–9
- Forbes JM, Anderson GF, Bleecker GC, Rossi EC, Moss GS. Blood transfusion costs: a multicenter study. Transfusion 1991; 31: 318–23
- Columbus woman wins $12 million AIDS judgment. The Columbus Dispatch March 9, 1990; 1
- Goodnough LT, Rudnick S, Price TH, et al. Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy. N Engl J Med 1989; 321: 1163–8